Fact-Check Disputes Trump's Claims on Medicaid Drug Savings
In a FactCheck.org analysis, the organization reports that President Trump, CMS Administrator Mehmet Oz, and HHS Secretary Robert F. Kennedy Jr. have overstated likely Medicaid savings from "most favored nation" drug pricing deals with pharmaceutical manufacturers. Trump cited a Council of Economic Advisers estimate of $64 billion in savings over 10 years, split between federal and state governments, but experts including KFF's Robin Rudowitz and Georgetown's Edwin Park say key details, which drugs are covered, how many states will participate, and deal duration, remain confidential and unclear. The administration's GENEROUS model reportedly covers "hundreds" of drugs, with CMS estimating up to $5.2 billion in annual rebates depending on state and drug participation. FactCheck.org notes the White House's own projections put initial state savings at under 2% of annual Medicaid drug spending, diminishing over time.